Blog

CIRM Grants ViaCyte $1.4M to Create Immune-Evasive Pluripotent Stem Cell Lines – PR Newswire (press release)

CIRM Grants ViaCyte $1.4M to Create Immune-Evasive Pluripotent Stem Cell Lines
PR Newswire (press release)
SAN DIEGO, Dec. 15, 2017 /PRNewswire/ — ViaCyte, Inc., a privately-held regenerative medicine company, today announced that the California Institute for Regenerative Medicine (CIRM) approved a grant of $1.4 million to support the initial development

and more »

2017-12-15 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.